---
title: "BAMC released its performance for the first half of the year, with a net profit attributable to the parent company of 676 million yuan, an increase of 6.05%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253453290.md"
description: "According to the Zhitong Finance APP, BAMC released its semi-annual report for 2025, with operating revenue of 10.221 billion yuan, a year-on-year increase of 15.21%. The net profit attributable to shareholders of the listed company was 676 million yuan, a year-on-year increase of 6.05%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 655 million yuan, a year-on-year increase of 7.88%. The basic earnings per share were 0.83 yuan"
datetime: "2025-08-18T11:29:14.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253453290.md)
  - [en](https://longbridge.com/en/news/253453290.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253453290.md)
---

# BAMC released its performance for the first half of the year, with a net profit attributable to the parent company of 676 million yuan, an increase of 6.05%

According to the Zhitong Finance APP, BAMC (601137.SH) released its semi-annual report for 2025, showing an operating income of 10.221 billion yuan, a year-on-year increase of 15.21%. The net profit attributable to shareholders of the listed company was 676 million yuan, a year-on-year increase of 6.05%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 655 million yuan, a year-on-year increase of 7.88%. The basic earnings per share were 0.83 yuan

### Related Stocks

- [601137.CN](https://longbridge.com/en/quote/601137.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [11:05 ETThe Church of Jesus Christ of Latter-day Saints Commits $25 Million to the UNICEF-led Child Nutrition Fund](https://longbridge.com/en/news/287088476.md)
- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)